Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

605.25 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30
Open 605.25
Bid (Size) 605.26 (1)
Ask (Size) 620.10 (1)
Prev. Close 605.25
Today's Range 605.25 - 605.25
52wk Range 441.00 - 686.62
Shares Outstanding 91,779,465
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Notable ETF Outflow Detected - IUSG, REGN, KLAC, SPGI
Symbols mentioned in this story: IUSG, REGN, KLAC, SPGI Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade. The Dow Jones settled higher by around 100 points ... 
Tags Futures News AXP
From Benzinga

Performance

YTD
-3.48%
-3.48%
1 Month
-4.65%
-4.65%
3 Month
+2.21%
+2.21%
6 Month
+4.17%
+4.17%
1 Year
+10.41%
+10.41%

More News

Read More
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
Tags Covid/19 News Omicron
From Benzinga
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
Tags UK:GSK GSK PFE
From MarketWatch
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
Tags Top Stories Coronavirus LLY
From Benzinga
IBD 50 Stocks To Watch: Biotech Leader Regeneron Eyes New Buy Point In Volatile Market
From Investor's Business Daily
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
Tags SNY Biotech Briefs
From Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
Tags Market News Benzinga News
From Benzinga
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
Tags COVID/19 Coronavirus News REGN
From Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
Tags IMAB Market News contributors
From Benzinga
Notable ETF Outflow Detected - IUSG, REGN, MMC, DE
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.